What Happened: Firms like Becton Dickinson and Babson Diagnostics have been working on technologies to overcome the hurdles that led to Theranos’s downfall. These companies have introduced their finger-prick blood tests in Austin, Texas, marking a significant departure from the traditional method of drawing blood from a vein, The Wall Street Journal reported on Friday.

Why It Matters: The new finger-prick blood tests are a game-changer for individuals who fear needles or struggle with traditional blood draws. These tests are less painful, quicker, and can be administered by pharmacists, making them more accessible. Moreover, they use significantly less blood, reducing waste and making the process more efficient. Holmes, the disgraced founder of Theranos, had a similar vision but her company’s downfall came after the promised revolutionary blood-testing technology was revealed to be non-existent.

As these tests gain popularity, companies like Becton and Babson must prove their accuracy and reliability to earn the trust of doctors and patients. Both companies have stated that clinical studies show their finger-prick blood tests are clinically equivalent to standard venous tests and plan to publish their results in a medical journal.